OSHIH Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oshih, and when can generic versions of Oshih launch?
Oshih is a drug marketed by Aurobindo Pharma and is included in one NDA.
The generic ingredient in OSHIH is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for OSHIH
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OSHIH at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for OSHIH
US Patents and Regulatory Information for OSHIH
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma | OSHIH | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 216558-001 | Dec 6, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |